The global interventional cardiology devices market, valued at US$26.32 billion in 2023, is forecasted to grow at a robust ...

Surmodics, Inc. SRDX recently announced the successful early clinical use of the company’s Pounce LP (Low Profile) Thrombectomy System. With the addition of a low-profile device, the Surmodics ...

The global neurovascular device market is projected to grow from USD 3.0 billion in 2024 to USD 3.9 billion by 2034, ...

However, high cost of neurovascular devices and dearth of qualified neurosurgeons required to handle these devices restrict growth of the market. Conversely, high growth rate exhibited by developing ...

Fintel reports that on December 17, 2024, Oppenheimer initiated coverage of Inari Medical (NasdaqGS:NARI) with a Outperform ...

In addition, other factors such as increase in technological advancements related to neurovascular devices also drive the growth of the U.S. neurovascular devices market. Neurovascular devices are ...

In addition, manual thrombectomy was associated with a lower ... to differences in patient selection, devices and study methodology. Moreover, many patients enrolled in these trials had a small ...

Inquis Medical is a clinical-stage medical device company dedicated to bringing next-generation thrombectomy systems to market. Its flagship product, the Aventus Precision Thrombectomy System ...

for its ClotTriever Thrombectomy System for DVT. This announcement follows the regulatory approval of the ClotTriever system by the Pharmaceuticals and Medical Devices Agency (PMDA) in December 2023.

for its ClotTriever Thrombectomy System for DVT. This announcement follows the regulatory approval of the ClotTriever system by the Pharmaceuticals and Medical Devices Agency (PMDA) in December 2023.